North Star Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-880
| Closed | -$38K | – | 992 |
|
2019
Q4 | $38K | Hold |
880
| – | – | ﹤0.01% | 601 |
|
2019
Q3 | $32K | Buy |
+880
| New | +$32K | ﹤0.01% | 625 |
|
2019
Q2 | – | Sell |
-880
| Closed | -$24K | – | 393 |
|
2019
Q1 | $24K | Hold |
880
| – | – | ﹤0.01% | 690 |
|
2018
Q4 | $14K | Hold |
880
| – | – | ﹤0.01% | 736 |
|
2018
Q3 | $18K | Hold |
880
| – | – | ﹤0.01% | 738 |
|
2018
Q2 | $13K | Hold |
880
| – | – | ﹤0.01% | 797 |
|
2018
Q1 | $20K | Hold |
880
| – | – | ﹤0.01% | 731 |
|
2017
Q4 | $26K | Hold |
880
| – | – | ﹤0.01% | 669 |
|
2017
Q3 | $33K | Hold |
880
| – | – | ﹤0.01% | 616 |
|
2017
Q2 | $25K | Hold |
880
| – | – | ﹤0.01% | 666 |
|
2017
Q1 | $30K | Hold |
880
| – | – | ﹤0.01% | 603 |
|
2016
Q4 | $25K | Hold |
880
| – | – | ﹤0.01% | 599 |
|
2016
Q3 | $28K | Hold |
880
| – | – | 0.01% | 481 |
|
2016
Q2 | $29K | Hold |
880
| – | – | 0.01% | 475 |
|
2016
Q1 | $25K | Hold |
880
| – | – | ﹤0.01% | 472 |
|
2015
Q4 | $31K | Hold |
880
| – | – | 0.01% | 446 |
|
2015
Q3 | $29K | Hold |
880
| – | – | 0.01% | 456 |
|
2015
Q2 | $37K | Hold |
880
| – | – | 0.01% | 422 |
|
2015
Q1 | $29K | Hold |
880
| – | – | 0.01% | 438 |
|
2014
Q4 | $28K | Hold |
880
| – | – | 0.01% | 437 |
|
2014
Q3 | $22K | Hold |
880
| – | – | ﹤0.01% | 449 |
|
2014
Q2 | $20K | Hold |
880
| – | – | ﹤0.01% | 486 |
|
2014
Q1 | $21K | Buy |
+880
| New | +$21K | ﹤0.01% | 464 |
|